Concepedia

Yijiang Shi

YS

Statistics

Publications

28

Citations

2.8K

H-Index

22

Active since

2001

Affiliations

University of California, Los Angeles(Current)

UCLA Jonsson Comprehensive Cancer Center

VA Greater Los Angeles Healthcare System

West Los Angeles College

UCLA Medical Center

Yijiang Shi is an author at University of California, Los Angeles specializing in multiple myeloma, oncology, and medicine.

Publications per year

2001–2017

28

Publications

28

Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade

Yijiang Shi, Huajun Yan, Patrick Frost et al. · Molecular Cancer Therapeutics · 2005 · 370 citations · Full text

Medicine, Cancer Biology, Pharmacology +14

AKT Activity Determines Sensitivity to Mammalian Target of Rapamycin (mTOR) Inhibitors by Regulating Cyclin D1 and c-myc Expression

Joseph Gera, Ingo K. Mellinghoff, Yijiang Shi et al. · Journal of Biological Chemistry · 2004 · 329 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779.

Yijiang Shi, Joseph Gera, Liping Hu et al. · PubMed · 2002 · 234 citations

Medicine, Oncology, Pharmacology +17

The AKT kinase is activated in multiple myeloma tumor cells

Jung-Hsin Hsu, Yijiang Shi, Stanisław Krajewski et al. · Blood · 2001 · 199 citations · Full text

Medicine, Cancer Biology, Oncology +13

In vivo antitumor effects of the mTOR inhibitor CCI-779 against human multiple myeloma cells in a xenograft model

Patrick Frost, Farhad Moatamed, Bao Hoang et al. · Blood · 2004 · 188 citations · Full text

Medicine, Oncology, Pharmacology +11

1–5 of 28